Literature DB >> 8093869

Altered esophageal pain threshold in irritable bowel syndrome.

M Costantini1, G C Sturniolo, G Zaninotto, R D'Incà, R Polo, R Naccarato, E Ancona.   

Abstract

Gut motility disorders and altered pain perception were reported in patients with irritable bowel syndrome (IBS). To verify foregut involvement in IBS, we studied 30 patients using esophageal manometry and 24-hr pH monitoring of the distal esophagus. Two subgroups of patients underwent esophageal provocative tests (bethanechol 50 micrograms/kg subcutaneously and esophageal balloon distension test). Twelve healthy volunteers formed a control group. A pain threshold on esophageal distension significantly lower than in healthy subjects (11.5 +/- 1 ml vs 22.2 +/- 1.7 ml, P < 0.01) was found in IBS patients. On the other hand, no differences between patients and controls were detected in lower esophageal sphincter pressure and length, esophageal body motility, or GER pattern; furthermore, bethanechol stimulation elicited similar esophageal body motility changes. Our study could confirm no detectable basal or bethanechol-induced esophageal motility disorders in IBS patients, nor enhanced GER. Esophageal involvement in IBS consists of a lower pain threshold on esophageal distension, possibly reflecting an altered visceral receptor sensitivity or modulation throughout the gut.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093869     DOI: 10.1007/bf01307536

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  Psychological characteristics of patients with the irritable bowel syndrome.

Authors:  R L Palmer; E Stonehill; A H Crisp; S L Waller; J J Misiewicz
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

2.  The effect of cholecystectomy on oesophageal symptoms.

Authors:  J R Barker; J Alexander-Williams
Journal:  Br J Surg       Date:  1974-05       Impact factor: 6.939

Review 3.  Colonic myoelectric activity in the irritable bowel syndrome.

Authors:  W J Snape; G M Carlson; S Cohen
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

4.  Abnormal sensory perception in patients with esophageal chest pain.

Authors:  J E Richter; C F Barish; D O Castell
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

5.  Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects.

Authors:  A Prior; D G Maxton; P J Whorwell
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

6.  Abnormal vagal function in irritable bowel syndrome.

Authors:  H L Smart; M Atkinson
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

7.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

8.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

Authors:  J E Kellow; S F Phillips
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

9.  Esophageal function in patients with reflux-induced strictures and its relevance to surgical treatment.

Authors:  G Zaninotto; T R DeMeester; C G Bremner; T C Smyrk; S C Cheng
Journal:  Ann Thorac Surg       Date:  1989-03       Impact factor: 4.330

10.  Gynaecological consultation in patients with the irritable bowel syndrome.

Authors:  A Prior; P J Whorwell
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

View more
  34 in total

Review 1.  Spinal and supraspinal modulation of visceral sensation.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Functional Gastroesophageal Reflux Disease (GERD).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 3.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

Authors:  Bin Feng; Jun Ho La; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 4.  Centrally acting agents and visceral sensitivity.

Authors:  J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

5.  Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms.

Authors:  Joseph Zimmerman
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 6.  Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.

Authors:  Nicola de Bortoli; Irene Martinucci; Massimo Bellini; Edoardo Savarino; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

7.  Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity.

Authors:  K C Trimble; R Farouk; A Pryde; S Douglas; R C Heading
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity.

Authors:  Marie C M Halliez; Jean-Paul Motta; Troy D Feener; Gaetan Guérin; Laetitia LeGoff; Arnaud François; Elodie Colasse; Loic Favennec; Gilles Gargala; Tamia K Lapointe; Christophe Altier; André G Buret
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

Review 10.  Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?

Authors:  Anita Gasiorowska; Choo Hean Poh; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.